http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#Head http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko http://www.nanopub.org/nschema#hasAssertion http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#assertion http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko http://www.nanopub.org/nschema#hasProvenance http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#provenance http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko http://www.nanopub.org/nschema#hasPublicationInfo http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#pubinfo http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#assertion http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_1 http://semanticscience.org/resource/SIO_000139 http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_2 http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://amigo.geneontology.org/amigo/term/GO:0016301 http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_2 http://purl.obolibrary.org/obo/RO_0002204 http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=6876 http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080 http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_3 http://purl.obolibrary.org/obo/BFO_0000066 http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=9606 http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_3 http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-diseases/Cisplatin%20resistance http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_3 http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://www.selventa.com/vocabulary/decreases http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_3 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_1 http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_3 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#assertion http://www.w3.org/2000/01/rdf-schema#label kin(p(HGNC:MAPK14)) -| path(SDIS:"Cisplatin resistance") http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#provenance http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/description Approximately 61,000 statements. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/rights Copyright (c) 2011-2012, Selventa. All rights reserved. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/title BEL Framework Large Corpus Document http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/authoredBy http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_5 http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/version 20131211 http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_4 http://www.w3.org/ns/prov#value Hsp27 effectively protected the cells from cisplatin-induced DNA fragmentation. The p38 inhibitors obviously decreased whereas Akt inhibitors markedly increased the apoptotic fraction in cisplatin-treated cells. Overexpression of Hsp27 doubly enhanced the drug-induced Akt activation while substantially depressing the drug-induced activation of ASK1 and p38. Hsp27 endues cells with cisplatin resistance via depression of the drug-induced ASK1/p38 activation and enhancement of the drug-induced Akt activation. http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_4 http://www.w3.org/ns/prov#wasQuotedFrom http://www.ncbi.nlm.nih.gov/pubmed/17504983 http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_5 http://www.w3.org/2000/01/rdf-schema#label Selventa http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#assertion http://www.w3.org/ns/prov#hadPrimarySource http://www.ncbi.nlm.nih.gov/pubmed/17504983 http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#_4 http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko#pubinfo http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko http://purl.org/dc/terms/created 2014-07-03T14:33:10.584+02:00 http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko http://purl.org/pav/createdBy http://orcid.org/0000-0001-6818-334X http://www.tkuhn.ch/bel2nanopub/RAFGv3R2HbGINC55euKAH2pLSYKyzj5pVnFl7Jo7cL9Ko http://purl.org/pav/createdBy http://orcid.org/0000-0002-1267-0234